Diagnostic anti-candidate vaccine virus (CVV) antibodies pairs and antigens for animal health (animal infectious disease ) testing in ELISA test,competitive ELISA test, blocking ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), and immunonephelometry

Catalog Number:GMP-AD-Pet-3
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
SKU GMP-AD-Pet-3 Categories , Tag

Product Details

A candidate vaccine virus (CVV) is an influenza (flu) virus that has been prepared by CDC or another public health partner that can be used by vaccine manufacturers to produce a flu vaccine. In addition to preparing CVVs for seasonal flu vaccine production, CDC routinely develops CVVs for novel avian influenza (bird flu) viruses with pandemic potential as part of pandemic preparedness activities. Some novel bird flu viruses with pandemic potential are “highly pathogenic avian influenza” (HPAI) viruses, which means they are deadly to domestic poultry, including chickens. Data collected through global and animal flu surveillance informs the selection of CVVs, and experts choose CVVs against bird flu viruses in nature (“wild type” viruses) that pose a risk to human health.Genemedi produces core animal health diagnostic ingredients-validated antibodies pairs Mouse anti-candidate vaccine virus (CVV) monoclonal antibodies and candidate vaccine virus (CVV) antigens for rapid test kit of animal infectious disease with candidate vaccine virus (CVV) to evaluate the animal health of Pet.The paired antibodies are both monoclonal antibody(mab).
All the antibodies and antiges of animal disease test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibody can act as a capture antibody and detection antibody. Antigens are validated as positive control materials.

Product Description

Cat No.

GMP-AD-Pet-3Ab

Antigens

candidate vaccine virus (CVV)

Antibody

Mouse anti-candidate vaccine virus (CVV) monoclonal antibodies

Resource (expression host)

hybridoma

Specics/Isotypes

Mouse IgG

Bioactivity validation

Antibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays in candidate vaccine virus (CVV) level test and Pet-diagnositcs.

Antigen description

Purity

Purity: ≥95% (SDS-PAGE)

Application

Paired antibody immunoassay validation in sandwich Elisa, Lateral flow immunoassay (LFIA), and other immunoassays;

Formulation

Lyophilized from sterile PBS, PH 7.4

Storage

Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.

GMP-AD-Pet-3Ag

Antigens

candidate vaccine virus (CVV)

Resource (expression host)

E.coli

Specics/Isotypes

candidate vaccine virus (CVV)

Bioactivity validation

Antibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays in candidate vaccine virus (CVV) level test and Pet-diagnositcs.

Tag

His

Antigen description

A candidate vaccine virus (CVV) is an influenza (flu) virus that has been prepared by CDC or another public health partner that can be used by vaccine manufacturers to produce a flu vaccine. In addition to preparing CVVs for seasonal flu vaccine production, CDC routinely develops CVVs for novel avian influenza (bird flu) viruses with pandemic potential as part of pandemic preparedness activities. Some novel bird flu viruses with pandemic potential are “highly pathogenic avian influenza” (HPAI) viruses, which means they are deadly to domestic poultry, including chickens. Data collected through global and animal flu surveillance informs the selection of CVVs, and experts choose CVVs against bird flu viruses in nature (“wild type” viruses) that pose a risk to human health.

Purity

Purity: ≥95% (SDS-PAGE)

Application

Paired antibody immunoassay validation in sandwich Elisa, Lateral flow immunoassay (LFIA), and other immunoassays;

Formulation

Lyophilized from sterile PBS, PH 7.4

Storage

Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Validated animal health diagnostic antibodies pairs and antigens for animal infectious diseases diagnostic testing in ELISA, Lateral flow immunoassay (LFIA) and other immunoassays

Livestock, poultry, and aquaculture are among the fastest growing and expanding agriculture sectors to fulfill the need of the growing population of humans. However, the growth in this sector is under the continuous increasing threats of infectious diseases worldwide. This menace is further aggravated by globalization in animal trade for various purposes. The sudden entry of an infectious disease in a new country or geographical location could lead to delayed diagnosis and rapid spread into the susceptible animal population. Hence, Animal diagnostics are critical for animal health, identifying health issues before they are otherwise able to be detected and supporting faster diagnosis and treatment planning. Diagnosis is an essential part of disease management and prevention. The importance of animal disease diagnostics laboratories is not a very recognized area of animal production but they are essential to animal health. It is important for not only animal producers, but also consumers to be aware of this resource. The application of innovative diagnostic technologies for the detection of animal pathogens at an early stage is essential in restricting the economic loss incurred due to emerging infectious animal diseases. The desirable characteristics of such diagnostic methods are easy to use, cost-effective, highly sensitive, and specific, coupled with the high-throughput detection capabilities. Genemedi provides diagnostic antibodies and antigens for the in vitro diagnosis of diseases from the pet, Cat/Feline, Dog/Canine, Rabbit, Bovines/Cattle, Ovines/Sheep, Caprine/Goat, Equine/Horse, Swine/Porcine/Pig, Avian/bird/poultry, Fish and so on.